论文部分内容阅读
目的对小儿肺炎支原体肺炎治疗中阿奇霉素联合痰热清的临床疗效进行分析。方法选取小儿肺炎支原体肺炎患儿86例,随机分为两组,对照组42例单用阿奇霉素治疗,观察组44例在对照组基础上加用痰热清治疗,对比两组临床疗效与安全性。结果观察组治疗总有效率显著高于对照组,复发率显著低于对照组(P<0.05),临床症状、体征消失时间显著短于对照组(P<0.05)。结论在小儿肺炎支原体肺炎的治疗中,阿奇霉素联合痰热清临床疗效显著,可有效缓解患儿临床症状,复发率较低,值得在临床中推广应用。
Objective To analyze the clinical efficacy of azithromycin combined with Tanreqing in the treatment of children with Mycoplasma pneumoniae pneumonia. Methods 86 cases of children with mycoplasma pneumoniae pneumonia were randomly divided into two groups, 42 cases in the control group were treated with azithromycin only, and 44 cases in the observation group were treated with Tanreqing on the basis of the control group. The clinical efficacy and safety were compared between the two groups . Results The total effective rate of the observation group was significantly higher than that of the control group, the recurrence rate was significantly lower than that of the control group (P <0.05), and the clinical symptoms and signs disappeared significantly shorter than that of the control group (P <0.05). Conclusion In the treatment of children with Mycoplasma pneumoniae pneumonia, azithromycin combined with Tanreqing clinical significant effect, can effectively alleviate the clinical symptoms in children, the recurrence rate is low, it is worth to promote the clinical application.